Cargando…

Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division

Introduction: Mineralocorticoid receptor (MR) activation within adipose tissue, triggers inflammation and metabolic syndrome development. The pharmacological blockade of MR provides beneficial effects for adipose tissue. Our study evaluates the impact of eplerenone implantation upon obesity. Experim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vecchiola, Andrea, Fuentes, Cristóbal A., Solar, Isidora, Lagos, Carlos F., Opazo, Maria Cecilia, Muñoz-Durango, Natalia, Riedel, Claudia A., Owen, Gareth I., Kalergis, Alexis M., Fardella, Carlos E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186315/ https://www.ncbi.nlm.nih.gov/pubmed/32373073 http://dx.doi.org/10.3389/fendo.2020.00223

Ejemplares similares

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
por: Muñoz-Durango, Natalia, et al.
Publicado: (2016)

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
por: Muñoz-Durango, N., et al.
Publicado: (2015)

Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro
por: Vecchiola, Andrea, et al.
Publicado: (2013)

LC–MS/MS Method for the Simultaneous Determination of Free Urinary Steroids
por: Allende, Fidel, et al.
Publicado: (2014)

Eplerenone ethanol solvate
por: Yang, Qian, et al.
Publicado: (2008)

SAT651 Human Adipose-derived Extracellular Vesicles (AdEVs) Increase Proinflammatory Markers In Renal And Endothelial Cells: An In Vitro Preliminary Study
por: Carvajal, Cristian A, et al.
Publicado: (2023)

Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
por: Tapia-Castillo, Alejandra, et al.
Publicado: (2021)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015)

Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Thyroid Gene Mutations in Pregnant and Breastfeeding Women Diagnosed With Transient Congenital Hypothyroidism: Implications for the Offspring’s Health
por: Opazo, Maria C., et al.
Publicado: (2021)

SAT-LB012 Differential miRNA-Transcriptomic and Proteomic Profile in Urinary Exosomes of Subjects with "Nonclassic" Apparent Mineralocorticoid Excess Syndrome
por: Tapia, Alejandra, et al.
Publicado: (2019)

RAAS inhibition and mortality in hypertension
por: Ferrari, Roberto
Publicado: (2013)

The RAAS Goodfellas in Cardiovascular System
por: Caputo, Ilaria, et al.
Publicado: (2023)

Eplerenone use in primary aldosteronism during pregnancy
por: Gunganah, Kirun, et al.
Publicado: (2015)

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

Averting Disease
Publicado: (1860)

Averting Disease
Publicado: (1876)

Comparison of Severity of COVID-19 Infection among Patients Using RAAS Inhibitors and Non-RAAS Inhibitors
por: Reddy, Paidi Ramakrishna, et al.
Publicado: (2021)

Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy
por: Nakano, Yujiro, et al.
Publicado: (2018)

Antifibrotic Roles of RAAS Blockers: Update
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

Downregulation of exosomal miR-192-5p and miR-204-5p in subjects with nonclassic apparent mineralocorticoid excess
por: Tapia-Castillo, Alejandra, et al.
Publicado: (2019)

Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012)

Possible dose-dependent effect of eplerenone on intraocular pressure
por: Razavi, Seyedeh Mehrsa Sadat, et al.
Publicado: (2023)

A Danger to Be Averted
Publicado: (1892)

The Role of Systolic Blood Pressure Reduction in Diastolic Dysfunction: RAAS Inhibition versus Non-RAAS Blood Pressure Lowering
por: Park, Sung-Ji
Publicado: (2020)

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
por: Moein, Hamid-Reza, et al.
Publicado: (2019)

Heavy Ion RAA summary Plots 2022
por: The ATLAS collaboration
Publicado: (2022)

RAAS-Blockade in COVID-19: The Ace of Spades?
por: Agarwal, Krishna A., et al.
Publicado: (2021)

RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021)

SAT-590 Role of Adipocyte Hyperplasia and Hypertrophy in the Release and Charge of Exosomes in Human Fat Cells
por: Vecchiola, Andrea, et al.
Publicado: (2020)

The relationship between adipose tissue RAAS activity and the risk factors of prediabetes: a systematic review and meta-analysis
por: Cassandra Mkhize, Bongeka, et al.
Publicado: (2023)

Development and Application of RAA Nucleic Acid Test Strip Assay and Double RAA Gel Electrophoresis Detection Methods for ASFV and CSFV
por: Wu, Keke, et al.
Publicado: (2022)

The Influence of Ionizing Radiation, Temperature, and Light on Eplerenone in the Solid State
por: Dettlaff, Katarzyna, et al.
Publicado: (2014)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
por: Chatziralli, Irini, et al.
Publicado: (2018)

Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
por: Sadda, Srinivas R.
Publicado: (2020)

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability
por: Khan, Muhammad Ayub, et al.
Publicado: (2021)

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
por: Anderson, William J., et al.
Publicado: (2022)

Averting danger from within
por: Bashyam, Hema
Publicado: (2008)

Heavy Ion Jet RAA Summary Plots 2023
por: The ATLAS collaboration
Publicado: (2023)

Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease
por: Bernardi, Stella, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ns073emmcg6i3tg7bin8vr6ci2